Table 3 Responsiveness parameters at 6-month follow-up in EQ-5D-5 L index and EQ-VAS among patients with Graves’ disease
From: Psychometric properties of EQ-5D-5L for use in patients with Graves’ disease
EQ-5D-5 L Index score | EQ-VAS score | |||||
|---|---|---|---|---|---|---|
Worsened (n = 21) | Unchanged (n = 38) | Improved (n = 41) | Worsened (n = 21) | Unchanged (n = 38) | Improved (n = 41) | |
Mean (SD) | ||||||
baseline | 0.92 (0.08) | 0.93 (0.08) | 0.92 (0.11) | 83.10 (9.42) | 78.95 (12.74) | 78.12 (14.34) |
6-month | 0.87 (0.10) | 0.92 (0.08) | 0.90 (0.14) | 72.29 (15.58) | 77.97 (14.69) | 80.83 (13.90) |
change | -0.05 (0.12) | -0.01 (0.09) | -0.02 (0.10) | -10.81 (10.76) | -0.97 (13.85) | 2.71 (13.27) |
P-value | 0.027* | 0.358 | 0.283 | < 0.001* | 0.971 | 0.257 |
SES (95%CI) | -0.66 (-1.30,0.06) | - | -0.16 (-0.43,0.13) | -1.15 (-1.69, -0.75) | - | 0.19 (-0.07,0.47) |
SRM (95%CI) | -0.42 (-0.84,0.04) | - | -0.17 (-0.48,0.14) | -1.00 (-1.48, -0.66) | - | 0.20 (-0.08,0.50) |